Trials that use: P-values
New to this method? Read the tutorial →
10,201 results
- Application of 3D Printing Technique in Small Pulmonary Nodule Localization: Complete Statistical AnalysisIndependent statistical analysis of Application of 3D Printing Technique in Small Pulmonary Nodule Localization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02952261).
- Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients: Complete Statistical AnalysisIndependent statistical analysis of Application of Bioimpedance Spectroscopy in Taiwan Dialysis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02325856).
- Application of Ideal Binary Masking to Disordered Speech: Complete Statistical AnalysisIndependent statistical analysis of Application of Ideal Binary Masking to Disordered Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05244603).
- Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population: Complete Statistical AnalysisIndependent statistical analysis of Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- APPLY-PNHIndependent statistical analysis of Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment: primary endpoint results, effect estimate with confidence…
- APPOSEIndependent statistical analysis of Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- APPRISE 1Independent statistical analysis of Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Approach to Sexuality From Occupational Therapy in People With Acquired Brain Injury in Subacute Stage: Complete Statistical AnalysisIndependent statistical analysis of Approach to Sexuality From Occupational Therapy in People With Acquired Brain Injury in Subacute Stage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Appy-PATIndependent statistical analysis of Randomized Controlled Trial of a Patient Activation Tool in Pediatric Appendicitis (Antibiotics Alone vs. Appendectomy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00659945).
- APROPOSIndependent statistical analysis of A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01907269).
- APSOEMIndependent statistical analysis of Cognitive Function in Elderly Marathon Runners: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01045031).
- AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period: Complete Statistical AnalysisIndependent statistical analysis of AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ARIndependent statistical analysis of Augmented Reality Distraction for Reducing Pain in Pediatric Dental Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06954883).
- ARAMISIndependent statistical analysis of the phase 3 ARAMIS trial of darolutamide versus placebo in men with high-risk non-metastatic castration-resistant prostate cancer, including metastasis-free survival, overall survival, time-to-event methods, and statistical interpretation.
- ARASENSIndependent statistical analysis of ARASENS, the randomized phase 3 trial of darolutamide plus standard androgen deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer, including time-to-event methodology, reported hazard ratios, confidence intervals,…
- ARBIndependent statistical analysis of Angiotensin II Blockade and Inflammation in Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01684748).
- ARC001Independent statistical analysis of Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ARCADIANIndependent statistical analysis of Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04648033).
- ARDAIndependent statistical analysis of A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy: primary endpoint…
- AREDS2A complete statistical analysis of AREDS2, the randomized phase 3 trial evaluating lutein/zeaxanthin and DHA/EPA in people at moderate to high risk for progression of age-related macular degeneration, including time-to-event methodology, hazard…
- ARESTIndependent statistical analysis of Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ARGONIndependent statistical analysis of Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ARICAIndependent statistical analysis of AdheRence to Inhaled Corticosteroids in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03769519).
- ARIEL3Independent statistical analysis of the phase 3 ARIEL3 trial of rucaparib as switch maintenance after platinum in relapsed high-grade serous or endometrioid ovarian cancer, including trial design, progression-free survival, Cox modeling, hazard…
- ARIESComplete statistical analysis of the ARIES phase 3 trial of mirabegron versus placebo in patients with symptoms of overactive bladder, including trial design, ANCOVA methodology, primary and secondary endpoint results, multiplicity, missing-data…
- Arimoclomol in Amyotropic Lateral Sclerosis – Open Label Extension Trial: Complete Statistical AnalysisIndependent statistical analysis of Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03836716).
- ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection: Complete Statistical AnalysisIndependent statistical analysis of ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study: Complete Statistical AnalysisIndependent statistical analysis of Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05522153).
- ARISTOTLEIndependent statistical analysis of ARISTOTLE (NCT00412984), including trial design, time-to-event endpoints, Cox proportional-hazards methodology, hazard ratios, confidence intervals, safety results, and statistical interpretation.
- ARL/20/277Independent statistical analysis of Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ARMIndependent statistical analysis of CoolSculpting the Upper Arm Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02669329).
- Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients: Complete Statistical AnalysisIndependent statistical analysis of Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ARMOURIndependent statistical analysis of Proximal Protection With The Mo.Ma Device During Carotid Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744523).
- ARMSIndependent statistical analysis of Automated Reinforcement Management System (ARMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04656925).
- ARRIVEIndependent statistical analysis of A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease: primary endpoint results, effect estimate with confidence interval,…
- ARRIVE USIndependent statistical analysis of Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ARRIVE- EUIndependent statistical analysis of Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ART-ADIndependent statistical analysis of Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ARTEMIS-IPFIndependent statistical analysis of ARTEMIS-IPF, the randomized phase 3 trial of ambrisentan versus placebo in idiopathic pulmonary fibrosis, including its time-to-event endpoint, hazard ratio, secondary analyses, statistical methods, and interpretation.
- Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear: Complete Statistical AnalysisIndependent statistical analysis of Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00549172).
- ARTISTIndependent statistical analysis of Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03991013).
- ARTISTSIndependent statistical analysis of Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ARTISTYKIndependent statistical analysis of A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: primary endpoint results, effect estimate with confidence…
- ARTS-HFIndependent statistical analysis of the ARTS-HF phase 2 trial of finerenone in worsening chronic heart failure with left ventricular systolic dysfunction and selected diabetes or chronic kidney disease populations.
- ARTSS-2Independent statistical analysis of Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- AS900672-Enriched in Ovulation Induction: Complete Statistical AnalysisIndependent statistical analysis of AS900672-Enriched in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553514).
- ASCENDIndependent statistical analysis of Assessing Symptomatic Clinical Episodes in Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595579).